Minimally Invasive Pituitary Surgery in a Hemorrhagic Necrosis of Adenoma During Pregnancy

Abstract

A 29-year-old woman with a prolactin microadenoma was under good control with bromocriptine (BCP) therapy until she became pregnant, when the treatment was stopped. During the third trimester of pregnancy the patient presented a unilateral visual loss and intermittent headaches. BCP was restarted and one week later she developed a complete ophthalmoplegia on the other side. The patient was submitted to an endoscopic transnasal transeptal resection of a hematoma and tumoral tissue in the pituitary region. One month after surgery, at 39 weeks of gestation, the patient spontaneously delivered a healthy girl weighing 3 kg, with an Apgar score of 9 and 10 at five minutes. This is the first case in the literature of a pregnant woman with second and third cranial nerve lesions, submitted to minimally invasive neuroendoscopic transnasal transsphenoidal approach in the third trimester of pregnancy.

Key words

Pregnancy - pituitary apolexy - endoscope - minimally invasive

References

• 1 Horvath E, Kovacs K. The adenohypophysis. In: Kovacs K, Asa SL (ed). Functional Endocrine Pathology. Boston: Blackwell Sciences 1991: 245-281
• 2 Molith M E. Management of prolactinomas during pregnancy.  J Reprod Med. 1999;  44 1121-1126
• 3 Randeva H, Davis M, Prelevic G. Prolactinoma and pregnancy.  Br J Obs Gyn. 2000;  107 1064-1068
• 4 Ester A D, Sanders T G, Vines F S. Size and shape of the pituitary gland during pregnancy and post partum: Measurement with MR imaging.  Radiology. 1991;  181 531-532
• 5 Miki Y, Asato R, Okumura R. Anterior pituitary gland in pregnancy: Hyperintensity at MR.  Radiology. 1993;  187 223-229
• 6 Dinç H, Esen F, Demirci A. Pituitary dimensions and volume measurements in pregnancy and post partum.  Acta Radiol. 1998;  39 64-69
• 7 Vician L, Shupnik M, Gorski J. Effects of estrogen on primary ovine pituitary cell cultures: Stimulation of prolactin secretion, synthesis, and preprolactin messenger ribonucleic acid activity.  Endocrinology. 1979;  104 736-743
• 8 Maurer R. Relationship between estradiol, ergocryptine, and thyroid hormone: Effects on prolactin synthesis and prolactin messenger ribonucleic acid levels.  Endocrinology. 1982;  110 1515-1520
• 9 Rakoff J, Yen S. Progesterone induced acute release of prolactin in estrogen primed ovariectomized women.  J Clin Endocrinol Metab. 1978;  47 918-922
• 10 Asa S, Penz C, Kovacs K, Ezrin C. Prolactin cells in the human pituitary: a quantitative immunocytochemical analysis.  Arch Pathol Lab Med. 1982;  106 360-363
• 11 Pressman E, Zeidman S, Reddy U, Epstein J, Brem H. Differentiating lymphocytic adenohypophysitis from pituitary adenoma in the peripartum patient.  J Reprod Med. 1995;  40 251-259
• 12 Thorner M O, Perryman R I, Rogol A D, Conway B P, Macleod R M, Login I S. Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine.  J Clin Endocrinol Metab. 1981;  53 480-483
• 13 Shanis B S, Check J H. Relative resistance of a microprolactinoma to bromocriptine therapy during pregnancy.  Gynecol Endocrinol. 1996;  10 91-94
• 14 Gemzell C, Wang C F. Outcome of pregnancy in women pituitary adenomas.  Fertil Steril. 1979;  31 363-372
• 15 Ahmed M, Al-Dossary E, Woodhouse N J. Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies.  Fertil Steril. 1992;  58 492-497
• 16 Cunnah D, Besser M. Management of prolactinoma.  Clin Endocrinol (Oxf). 1990;  34 231-235
• 17 Ruiz-Velasco V, Tolis G. Pregnancy in hyperprolactinemic women.  Fertil Steril. 1984;  41 793-805
• 18 Molith M E. Pregnancy and the hyperprolactinemic woman.  N Engl J Med. 1985;  312 1364-1370
• 19 Bergh T, Nillus S J, Enoksson P, Larson G, Wide L. Bromocriptin-induced pregnancies in women with large prolactinomas.  Clin Endocrinol (Oxf). 1982;  17 625-631
• 20 Child D, Gordon H, Mashiter K, Joplin G. Pregnancy, prolactin and pituitary tumors.  Br Med J. 1975;  4 87-89
• 21 Krupp P, Monka C, Richter K. The safety aspects of infertility treatments. Proc of the Second World Congress of Gynecology and Obstetrics, Rio de Janeiro,. October 1988
• 22 Konopka P, Raymond J, Meceron R. Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas.  Am J Obstet Gynecol. 1983;  146 935-938
• 23 Musolino N, Bronstein M. Prolactinomas and pregnancy: Use of dopamine agonists: Bromocriptime and cabergoline. Proc of the 6^th International Pituitary Congress, Long Beach, California. 1999
• 24 van Roon E, van der Vijver J C, Gerretsen G, Hekster R E, Waddendorff R A. Rapid regression of a suprasellar estending prolactinoma after bromocriptine treatment during pregnancy.  Fertil Steril. 1981;  36 173-177
• 25 Crosignani P G, Mattei A M, Severini V, Cavioni V, Maggioni P, Testa G. Long-term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women.  Eur J Obs Rep Biology. 1992;  40 175-180
• 26 Modena G, Portioli I. Delivery after bromocriptine therapy.  Lancet. 1977;  2 558
• 27 Yuen B. Bromocriptine, pituitary tumours, and pregnancy.  Lancet. 1978;  2 1314
• 28 Griffith R W, Turkalj I, Braun P. Outcome of pregnancy in mothers given bromocriptine.  Br J Clin Pharmacol. 1978;  5 227-231
• 29 Parks D. Drug therapy: bromocriptine.  New Engl J Med. 1979;  301 873-878
• 30 Turkalj I, Braun P, Krupp P. Surveillance of bromocriptine in pregnancy.  JAMA. 1982;  247 1589-1591
• 31 Raymond J P, Goldsteine E, Kanopka P, Lelu M F, Merceron R E, Loria Y. Follow up of children born of bromocriptine-treated mothers.  Horm Res. 1985;  22 239-246
• 32 Freeman R, Wezenter B, Silverstein M, Kuo D, Weiss K, Kantrowitz A. Pregnancy-associated subacute hemorrhage into a prolactinoma resulting in diabetes insipidus.  Fertil Steril. 1992;  58 427-429
• 33 Labauge R, Pages A, Pages M, Ribstein J, Richard L. Necrose hemorragique d'un adenome hypophysaire polyoncose endocrinienne.  Rev Neurol (Paris). 1982;  138 149-158
• 34 Saunders N. Prolactinoma during pregnancy causing compression symptoms responding to bromocriptine therapy.  Postgrad Med J. 1985;  61 829-830
• 35 Wykes W. Prolactinoma presenting with intermittent third nerve palsy.  Br J Ophthalmol. 1986;  70 706-707
• 36 Fong L, Fabinyi G. Ophthalmic manifestations of pituitary apoplexy.  Med J Aust. 1985;  142 142-143
• 37 Crosignani P G, Ferrari C, Mattei A M. Visual field defects and reduced visual acuity during pregnancy in two patients with prolactinoma: rapid regression of symptoms under bromocriptine. Case report.  Br J Obstet Gynecol. 1984;  91 821-823
• 38 Holgren U, Bergstrand G, Hagenfeldt K, Werner S. Women with prolactinoma - effect of pregnancy and lactation on serum prolactin and tumor growth.  Acta Endocrinol. 1986;  111 452-459
• 39 Rasmussen C, Bergh T, Wide L. Prolactin secretion and menstrual function after long-term bromocriptine treatment.  Fertil Steril. 1987;  48 550-554
• 40 Crosignani P, Mattei A, Scarduelli C, Cavioni V, Boracchi P. Is pregnancy the best treatment for hyperprolactinaemia?.  Human Reprod. 1989;  4 910-912
• 41 Divers W, Yen S. Prolactin-producing microadenomas in pregnancy.  Obstet Gynecol. 1983;  61 425-429
• 42 Kupersmith M J, Rosemberg C, Keimberg D. Visual loss in pregnant women with pituitary adenomas.  Ann Intern Med. 1994;  121 437
• 43 Rjosk H, Fahlbusch R, Werder K. Influence of pregnancies on prolactinomas.  Acta Endocrinol. 1982;  100 337-346
• 44 Canales E S, Garcia I C, Ruiz J E, Zarate A. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy.  Fertil Steril. 1981;  36 524-526
• 45 Bergh T, Nillius S, Larsson S, Wide L. Effects of bromocriptine induced pregnancy on prolactin secreting pituitary tumors.  Acta Endocrinol (Copenh). 1981;  98 333-338
• 46 Goodman L A, Chang R J. Pregnancy after bromocriptine induced reduction of an extrasellar prolactin-secreting pituitary macroadenomas.  Obstet Gynecol. 1984;  64 (3 Suppl) 2s-7s
• 47 Coremblum B. Successful outcome of ergocryptine-induced pregnancies in twenty-one women with prolactina-secreting pituitary adenomas.  Fertil Steril. 1979;  32 183-186
• 48 Glick R P, Tiesi J Á. Subacute pituitary apoplexy: clinical and magnetic resonance imaging characteristics.  Neurosurgery. 1990;  27 214-219
• 49 Onesti S T, Wisniewski T, Post K D. Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients.  Neurosurg. 1990;  26 990-996
• 50 Gondim J, Pinheiro I. Neuroendoscopic endonasal transseptal approach to the sellar region: study of 30 cases.  Arq Neuropsiquiatr. 2001;  59 901-904